Market Cap 118.97B
Revenue (ttm) 402.07B
Net Income (ttm) 1.77B
EPS (ttm) N/A
PE Ratio 11.95
Forward PE 11.67
Profit Margin 0.44%
Debt to Equity Ratio 0.77
Volume 5,592,400
Avg Vol 8,200,010
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 13%
Beta 0.61
Analysts Strong Sell
Price Target $114.58

Company Profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
whiskyqueens
whiskyqueens Aug. 23 at 7:45 PM
$CVS just closed the week below this key supporting trendline, right after reaching the apex of the triangle. Likely a bearish breakout, to the downside 🔻 Currently at $93.14, gamma flip $102.00 — price is well below the flip, so this is negative gamma territory: moves tend to get amplified, not cushioned 🐻 Max -GEX is -688.7K at $85 — that's the level where a slide could pick up speed. Below current price, red dominates all the way down (90, 87.5, 85 all show consistent negative prints across expiries), so there's no real dealer floor between here and there. Max +GEX is 4.26M at $105 — that's well above spot, meaning meaningful dealer support doesn't show up until CVS reclaims $102+ (the flip itself). Until then, it's an unsupported tape
0 · Reply
peloswing
peloswing Aug. 23 at 7:11 PM
$CVS just closed the week below this key supporting trendline, right after reaching the apex of the triangle. Likely a bearish breakout, to the downside 🔻 Currently at $93.14, gamma flip $102.00 — price is well below the flip, so this is negative gamma territory: moves tend to get amplified, not cushioned 🐻 Max -GEX is -688.7K at $85 — that's the level where a slide could pick up speed. Below current price, red dominates all the way down (90, 87.5, 85 all show consistent negative prints across expiries), so there's no real dealer floor between here and there. Max +GEX is 4.26M at $105 — that's well above spot, meaning meaningful dealer support doesn't show up until CVS reclaims $102+ (the flip itself). Until then, it's an unsupported tape.
0 · Reply
MonkMan
MonkMan Aug. 22 at 4:15 PM
$CVS thoughts on CVS? Was writing aggressive cover calls until earnings. Stock suks recently and IV fell. Thinking of buying long 100 calls too write against while restarting aggressive covers on stock. Looking to exist stock over 100 then while hanging on to calls for missed gains. Fyi long at like 60
0 · Reply
LuciaBlandy137
LuciaBlandy137 Aug. 22 at 3:42 PM
$UUP $NDAQ $NVCR $RNG $CVS UUP provides U.S.-dollar exposure, Nasdaq benefits from capital-markets activity, NovoCure advances cancer-treatment technologies, RingCentral benefits from cloud communications, and CVS benefits from healthcare and pharmacy demand. I'm watching currency trends, trading volumes, clinical milestones, enterprise communications, and healthcare utilization.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 3:06 AM
$CVS Price: $93.02 (-0.67%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.06% RSI: 21.2 | Momentum: Moderate Volume: -31.5% vs avg Volatility: 1.88% Support: $92.35 | Resistance: $110.00 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
EarlyT
EarlyT Aug. 21 at 10:35 PM
$CVS what is up with CVS now?
0 · Reply
pickxs
pickxs Aug. 21 at 4:54 PM
$CVS why?
1 · Reply
Cracker36
Cracker36 Aug. 21 at 1:38 PM
$CVS 95 today and 100 next week. Loaded up those cheap calls
0 · Reply
JamesRao878
JamesRao878 Aug. 20 at 7:30 AM
$BMO $MDT $BTI $CVS $SBUX Bank of Montreal benefits from financial activity, Medtronic benefits from medical-device demand, British American Tobacco remains tied to consumer-product trends, CVS benefits from healthcare utilization and pharmacy demand, and Starbucks benefits from beverage sales and store traffic. I'm watching credit quality, procedures, consumer volumes, healthcare utilization, and same-store sales.
0 · Reply
AnonMav
AnonMav Aug. 20 at 6:11 AM
$CVS the pace is too fast, you just won’t last
0 · Reply
Latest News on CVS
CVS Health price target raised to $114 from $104 at Argus

2026-08-19T12:50:37.000Z - 4 days ago

CVS Health price target raised to $114 from $104 at Argus


CVS Health Announces Board Changes

Aug 17, 2026, 4:15 PM EDT - 6 days ago

CVS Health Announces Board Changes


CVS Health price target raised to $118 from $111 at JPMorgan

2026-08-17T09:51:55.000Z - 6 days ago

CVS Health price target raised to $118 from $111 at JPMorgan


CVS Health price target raised to $107 from $94 at Baird

2026-08-06T13:20:31.000Z - 17 days ago

CVS Health price target raised to $107 from $94 at Baird


CVS Health price target raised to $126 from $122 at UBS

2026-08-06T10:36:22.000Z - 17 days ago

CVS Health price target raised to $126 from $122 at UBS


CVS Health price target raised to $108 from $106 at Barclays

2026-08-06T09:20:49.000Z - 17 days ago

CVS Health price target raised to $108 from $106 at Barclays


CVS Health Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 18 days ago

CVS Health Earnings Call Transcript: Q2 2026


CVS Health Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 18 days ago

CVS Health Quarterly report: Q2 2026


CVS Health Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 18 days ago

CVS Health Slides: Q2 2026


CVS Health Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 18 days ago

CVS Health Earnings release: Q2 2026


CVS Health announces revamp of weight management program

2026-08-05T10:45:52.000Z - 18 days ago

CVS Health announces revamp of weight management program

LLY


CVS Health reports Q2 adjusted EPS $2.58, consensus $1.85

2026-08-05T10:36:30.000Z - 18 days ago

CVS Health reports Q2 adjusted EPS $2.58, consensus $1.85


CVS raises annual profit forecast on improved drug revenues

Aug 5, 2026, 6:32 AM EDT - 18 days ago

CVS raises annual profit forecast on improved drug revenues


CVS's Turnaround Faces Its Next Test

Aug 4, 2026, 4:32 PM EDT - 19 days ago

CVS's Turnaround Faces Its Next Test


The Big 3: GOOGL, SMCI, CVS

Jul 24, 2026, 1:00 PM EDT - 4 weeks ago

The Big 3: GOOGL, SMCI, CVS

GOOG GOOGL SMCI


Pet medications now available at CVS Pharmacy®

Jul 21, 2026, 9:00 AM EDT - 4 weeks ago

Pet medications now available at CVS Pharmacy®


CVS Health declares quarterly dividend

Jul 10, 2026, 9:48 AM EDT - 6 weeks ago

CVS Health declares quarterly dividend


The Big 3: CVS, SLV, PLTR

Jul 1, 2026, 1:00 PM EDT - 7 weeks ago

The Big 3: CVS, SLV, PLTR

PLTR SLV


CVS is Using Fluency to Close Enterprise AI Deployment Gap

Jun 11, 2026, 10:43 AM EDT - 2 months ago

CVS is Using Fluency to Close Enterprise AI Deployment Gap


H1 Receives $40M Investment in Round Led by CVS Health Ventures

May 28, 2026, 11:00 AM EDT - 3 months ago

H1 Receives $40M Investment in Round Led by CVS Health Ventures


CVS brings back coverage for Lilly's obesity drug Zepbound

May 28, 2026, 6:47 AM EDT - 3 months ago

CVS brings back coverage for Lilly's obesity drug Zepbound

LLY


Glenview Capital Issues Statement on CVS Health

May 21, 2026, 4:15 PM EDT - 3 months ago

Glenview Capital Issues Statement on CVS Health


The Big 3: NKE, CVS, CSCO

May 20, 2026, 1:00 PM EDT - 3 months ago

The Big 3: NKE, CVS, CSCO

CSCO NKE


whiskyqueens
whiskyqueens Aug. 23 at 7:45 PM
$CVS just closed the week below this key supporting trendline, right after reaching the apex of the triangle. Likely a bearish breakout, to the downside 🔻 Currently at $93.14, gamma flip $102.00 — price is well below the flip, so this is negative gamma territory: moves tend to get amplified, not cushioned 🐻 Max -GEX is -688.7K at $85 — that's the level where a slide could pick up speed. Below current price, red dominates all the way down (90, 87.5, 85 all show consistent negative prints across expiries), so there's no real dealer floor between here and there. Max +GEX is 4.26M at $105 — that's well above spot, meaning meaningful dealer support doesn't show up until CVS reclaims $102+ (the flip itself). Until then, it's an unsupported tape
0 · Reply
peloswing
peloswing Aug. 23 at 7:11 PM
$CVS just closed the week below this key supporting trendline, right after reaching the apex of the triangle. Likely a bearish breakout, to the downside 🔻 Currently at $93.14, gamma flip $102.00 — price is well below the flip, so this is negative gamma territory: moves tend to get amplified, not cushioned 🐻 Max -GEX is -688.7K at $85 — that's the level where a slide could pick up speed. Below current price, red dominates all the way down (90, 87.5, 85 all show consistent negative prints across expiries), so there's no real dealer floor between here and there. Max +GEX is 4.26M at $105 — that's well above spot, meaning meaningful dealer support doesn't show up until CVS reclaims $102+ (the flip itself). Until then, it's an unsupported tape.
0 · Reply
MonkMan
MonkMan Aug. 22 at 4:15 PM
$CVS thoughts on CVS? Was writing aggressive cover calls until earnings. Stock suks recently and IV fell. Thinking of buying long 100 calls too write against while restarting aggressive covers on stock. Looking to exist stock over 100 then while hanging on to calls for missed gains. Fyi long at like 60
0 · Reply
LuciaBlandy137
LuciaBlandy137 Aug. 22 at 3:42 PM
$UUP $NDAQ $NVCR $RNG $CVS UUP provides U.S.-dollar exposure, Nasdaq benefits from capital-markets activity, NovoCure advances cancer-treatment technologies, RingCentral benefits from cloud communications, and CVS benefits from healthcare and pharmacy demand. I'm watching currency trends, trading volumes, clinical milestones, enterprise communications, and healthcare utilization.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 3:06 AM
$CVS Price: $93.02 (-0.67%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.06% RSI: 21.2 | Momentum: Moderate Volume: -31.5% vs avg Volatility: 1.88% Support: $92.35 | Resistance: $110.00 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
EarlyT
EarlyT Aug. 21 at 10:35 PM
$CVS what is up with CVS now?
0 · Reply
pickxs
pickxs Aug. 21 at 4:54 PM
$CVS why?
1 · Reply
Cracker36
Cracker36 Aug. 21 at 1:38 PM
$CVS 95 today and 100 next week. Loaded up those cheap calls
0 · Reply
JamesRao878
JamesRao878 Aug. 20 at 7:30 AM
$BMO $MDT $BTI $CVS $SBUX Bank of Montreal benefits from financial activity, Medtronic benefits from medical-device demand, British American Tobacco remains tied to consumer-product trends, CVS benefits from healthcare utilization and pharmacy demand, and Starbucks benefits from beverage sales and store traffic. I'm watching credit quality, procedures, consumer volumes, healthcare utilization, and same-store sales.
0 · Reply
AnonMav
AnonMav Aug. 20 at 6:11 AM
$CVS the pace is too fast, you just won’t last
0 · Reply
theoptionsplug
theoptionsplug Aug. 19 at 6:55 PM
Potential Inverse H&S formation on $CVS 👀⤴️
0 · Reply
MikeStocksLA
MikeStocksLA Aug. 19 at 4:45 PM
$CVS I'm a buyer here, 250 shares
0 · Reply
Reanimated666
Reanimated666 Aug. 19 at 3:23 PM
$CVS Buying all I can here
0 · Reply
CallYourMommy
CallYourMommy Aug. 18 at 3:26 PM
$CLOV - $CVS needs to slow new enrollment growth and protect margins because of rising healthcare costs that outpace federal payments. So many mixed signals in the marketplace right now https://x.com/modrnhealthcr/status/2089633350432514190?s=46&t=QgsWqL_F3zCLg6CG-bIVpA
0 · Reply
THE_TRADE
THE_TRADE Aug. 18 at 10:46 AM
$CVS It's still his core position and he still has powe an the others he appointed are still there
0 · Reply
EarlyT
EarlyT Aug. 18 at 2:49 AM
$CVS Larry left the BOD 8/13. Might be why CVS is down.
0 · Reply
MoneyMacG
MoneyMacG Aug. 17 at 8:50 PM
0 · Reply
HydrogenH2
HydrogenH2 Aug. 17 at 7:53 PM
$CVS You...make my day !! lol
0 · Reply
HydrogenH2
HydrogenH2 Aug. 17 at 7:50 PM
$CVS I'm adding some more !!
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 15 at 5:23 PM
$CVS CVS Health Corporation (NYSE: CVS) is gaining a surprising foothold in the GLP-1 boom through Wegovy while its turnaround gathers momentum. Is CVS stock being overlooked by healthcare investors? https://biotechhealthx.com/biotech-news/could-cvs-health-cvs-be-a-smart-long-term-buy-at-current-levels/
0 · Reply
AlmostMiddleClass
AlmostMiddleClass Aug. 15 at 7:02 AM
1 · Reply
Kosmos709
Kosmos709 Aug. 14 at 6:48 PM
0 · Reply